Home › NCT02817997

International Registry for Patients With Castleman Disease

ACCELERATE (Advancing Castleman Care With an Electronic Longitudinal Registry, E-Repository, And Treatment/Effectiveness Research): An International Registry for Patients With Castleman Disease

Who can join

All ages · All sexes

Inclusion Criteria:

* Person of any age
* Have a reference pathology report suggesting "Castleman disease" not limited to cutaneous involvement only that can be uploaded
* Be able to provide electronic informed consent, as per local regulations
* Deceased patients may also be enrolled when a reference pathology report suggesting "Castleman disease" can be supplied or when the ART is able to locate and upload such a pathology report.

Exclusion Criteria:

* Because this registry is designed to provide as wide a picture of routine clinical practice as possible, inclusion criteria are set deliberately wide and there are no exclusion criteria.

About the study

The purpose of this study is to collect clinical, laboratory, and patient survey data from patients with Castleman disease to improve understanding, diagnosis, and treatment of the disease. Funding source - FDA OOPD.

Sponsor: University of Pennsylvania · Participants: 1,000 · Started: 2016-10

Contact the study team

• Joshua Brandstadter, MD, PhD, MSc · Phone: 267-847-8220
• Bridget Austin, MSc · Phone: 2675869977

Official record on ClinicalTrials.gov — NCT02817997

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.